The Impact and Future of the Childhood Cancer Survivor Study: An Interview with Greg Armstrong, M.D.
September is Childhood Cancer Awareness month, an opportunity to learn more about pediatric cancer. Thanks to treatment advances, 83% of children diagnosed with cancer will survive at least 5 years after diagnosis. Unfortunately, many of these survivors will experience late effects, health problems later in life that are related to the cancer treatments they received as children. The NCI-supported Childhood Cancer Survivor Study (CCSS) has helped to identify late effects of childhood cancer treatments, and to develop strategies for preventing or better managing these effects, with the aim of improving survivors’ quality of life and long-term survival. In this interview, Greg Armstrong, M.D., of St. Jude Children’s Research Hospital, principal investigator of the CCSS, discusses some recent findings from the long-running study and its future directions.